Clinical Trial Update: Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating CTX-009 with or without CTX-471 for recurrent glioblastoma; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CTX-009 (CTX-009)
• CTX-471

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING